<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 750px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 750px;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "label": "A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KRAS", "label": "KRAS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BRAF", "label": "BRAF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ERB-2", "label": "ERB-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PTEN", "label": "PTEN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TP-53", "label": "TP-53", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "label": "A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BRCA1", "label": "BRCA1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BRCA2", "label": "BRCA2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WFDC2", "label": "WFDC2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MUC1", "label": "MUC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MUC4", "label": "MUC4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MUC16", "label": "MUC16", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "label": "AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AHRR", "label": "AHRR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPP1R3C", "label": "PPP1R3C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GALNT10", "label": "GALNT10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AHR", "label": "AHR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EGF", "label": "EGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FGF", "label": "FGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BID", "label": "BID", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CASP3", "label": "CASP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NOXA", "label": "NOXA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDKN2A", "label": "CDKN2A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TERT", "label": "TERT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ALDH1A1", "label": "ALDH1A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD44", "label": "CD44", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ABCG2", "label": "ABCG2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NANOG", "label": "NANOG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADRA1B", "label": "ADRA1B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADAM19", "label": "ADAM19", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADAMTS2", "label": "ADAMTS2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL23A1", "label": "COL23A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CPLX2", "label": "CPLX2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FABP6", "label": "FABP6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GABRA1", "label": "GABRA1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GABRA6", "label": "GABRA6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GABRB2", "label": "GABRB2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GABRP", "label": "GABRP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HNRNPAB", "label": "HNRNPAB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KCNIP1", "label": "KCNIP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LSM11", "label": "LSM11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAMDC2", "label": "MAMDC2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MFAP3", "label": "MFAP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MKRN2", "label": "MKRN2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MIR762HG", "label": "MIR762HG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NDST1", "label": "NDST1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NEURL1", "label": "NEURL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NSD1", "label": "NSD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PC", "label": "PC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RANBP17", "label": "RANBP17", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RNF130", "label": "RNF130", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SFXN1", "label": "SFXN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SH3PXD2B", "label": "SH3PXD2B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SLIT3", "label": "SLIT3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TENM2", "label": "TENM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::UBTD2", "label": "UBTD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::UIMC1", "label": "UIMC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZNF346", "label": "ZNF346", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NLRP12", "label": "NLRP12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PYROXD2", "label": "PYROXD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RASGEF1C", "label": "RASGEF1C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TBC1D9B", "label": "TBC1D9B", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::RAD51 as a Biomarker for Homologous Recombination Deficiency in High\u2010Grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 test", "label": "RAD51 as a Biomarker for Homologous Recombination Deficiency in High\u2010Grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 test", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::nan", "label": "nan", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RIPK4", "label": "RIPK4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "label": "RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TP53", "label": "TP53", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PAX8", "label": "PAX8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::E2F1", "label": "E2F1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::E2F8", "label": "E2F8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AURKB", "label": "AURKB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDCA5", "label": "CDCA5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CENPI", "label": "CENPI", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FOXM1", "label": "FOXM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MYBL2", "label": "MYBL2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ABCB1", "label": "ABCB1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "label": "Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RB1", "label": "RB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NF1", "label": "NF1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAD51B", "label": "RAD51B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IGF1R", "label": "IGF1R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FGFR", "label": "FGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ERBB2", "label": "ERBB2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EGFR", "label": "EGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PDGFR", "label": "PDGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::JAK1", "label": "JAK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::JAK2", "label": "JAK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::STAT3", "label": "STAT3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CTNNB1", "label": "CTNNB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AXIN1", "label": "AXIN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::APC", "label": "APC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RUNX3", "label": "RUNX3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CAMK2N1", "label": "CAMK2N1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ARNTL", "label": "ARNTL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FKBP1", "label": "FKBP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PAX9", "label": "PAX9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL11A1", "label": "COL11A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL6", "label": "IL6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL6ST", "label": "IL6ST", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RIPK3", "label": "RIPK3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MLKL", "label": "MLKL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AKT1", "label": "AKT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BCL2", "label": "BCL2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CASP8", "label": "CASP8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CASP9", "label": "CASP9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BAX", "label": "BAX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BAD", "label": "BAD", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BECN1", "label": "BECN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ERBB3", "label": "ERBB3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRKCI", "label": "PRKCI", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL6R", "label": "IL6R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::STK11", "label": "STK11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SIRT3", "label": "SIRT3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RBP4", "label": "RBP4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ALDH", "label": "ALDH", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FOXR2", "label": "FOXR2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "label": "Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "label": "Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MSLN", "label": "MSLN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RGS2", "label": "RGS2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FAM83A", "label": "FAM83A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MYO18B", "label": "MYO18B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MSX1", "label": "MSX1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TMEM88", "label": "TMEM88", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDK12", "label": "CDK12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAD51C", "label": "RAD51C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EMSY", "label": "EMSY", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MLH1", "label": "MLH1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RASSF1A", "label": "RASSF1A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ATG4A", "label": "ATG4A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HIST1H2BN", "label": "HIST1H2BN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ERCC1", "label": "ERCC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPIC", "label": "PPIC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RRM1", "label": "RRM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RRM2", "label": "RRM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MRP1", "label": "MRP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MDR1", "label": "MDR1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "label": "Role of different non-coding RNAs as ovarian Cancer biomarkers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HMBOX1", "label": "HMBOX1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LIAS", "label": "LIAS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MTR", "label": "MTR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NUDT4", "label": "NUDT4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MPHOSPH8", "label": "MPHOSPH8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FOXP1", "label": "FOXP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TWIST1", "label": "TWIST1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::YAP1", "label": "YAP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VEGFA", "label": "VEGFA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PIK3R3", "label": "PIK3R3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CLDN1", "label": "CLDN1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "label": "Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MYC", "label": "MYC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SMAD4", "label": "SMAD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EBF1", "label": "EBF1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NF1C", "label": "NF1C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ATF2", "label": "ATF2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MMP3", "label": "MMP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MMP9", "label": "MMP9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDKN1A", "label": "CDKN1A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SNAI1", "label": "SNAI1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VIM", "label": "VIM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZEB1", "label": "ZEB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MMP14", "label": "MMP14", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDKN2B", "label": "CDKN2B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TIMP1", "label": "TIMP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "label": "Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BCL10", "label": "BCL10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::S1PR1", "label": "S1PR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ESR1", "label": "ESR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RUNX2", "label": "RUNX2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ITGA5", "label": "ITGA5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PCDH9", "label": "PCDH9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLF12", "label": "KLF12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HK2", "label": "HK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BIRC5", "label": "BIRC5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FBXL10", "label": "FBXL10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DICER1", "label": "DICER1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DGCR8", "label": "DGCR8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::XPO5", "label": "XPO5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAN", "label": "RAN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AGO2", "label": "AGO2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TARBP2", "label": "TARBP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRKRA", "label": "PRKRA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PIK3CA", "label": "PIK3CA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PIK3CB", "label": "PIK3CB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GSTP1", "label": "GSTP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NAV3", "label": "NAV3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAP3K7", "label": "MAP3K7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HNRNPC", "label": "HNRNPC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NFIX", "label": "NFIX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CHD4", "label": "CHD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IRAK1", "label": "IRAK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TRAF6", "label": "TRAF6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HIF1A", "label": "HIF1A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EPAS1", "label": "EPAS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TAK1", "label": "TAK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CXCL1", "label": "CXCL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CXCL8", "label": "CXCL8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TNF", "label": "TNF", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "label": "Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EPCAM", "label": "EPCAM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HER2", "label": "HER2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WT1", "label": "WT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::P16", "label": "P16", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CK20", "label": "CK20", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CK8", "label": "CK8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CK18", "label": "CK18", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TFS-2", "label": "TFS-2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas", "label": "Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "label": "SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SLC11A2", "label": "SLC11A2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "label": "SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SPON1", "label": "SPON1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SPON1-NRG2\u0391", "label": "SPON1-NRG2\u0391", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SPON1-TRIM29", "label": "SPON1-TRIM29", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "label": "SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SUGT1", "label": "SUGT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PAX3", "label": "PAX3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FOXO1", "label": "FOXO1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EWS", "label": "EWS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FLI1", "label": "FLI1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GTF2F2", "label": "GTF2F2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NUFIP1", "label": "NUFIP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TRIM13", "label": "TRIM13", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MED4", "label": "MED4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GPALPP1", "label": "GPALPP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::UBE2L6", "label": "UBE2L6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NUDT8", "label": "NUDT8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PLAAT4", "label": "PLAAT4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LGALS17A", "label": "LGALS17A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PIGR", "label": "PIGR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::JAK", "label": "JAK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MTOR", "label": "MTOR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TNFA", "label": "TNFA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum CA125, CA199 and CEA combined detection \r\nfor epithelial ovarian cancer diagnosis: A meta\r\nanalysis", "label": "Serum CA125, CA199 and CEA combined detection \r\nfor epithelial ovarian cancer diagnosis: A meta\r\nanalysis", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "label": "Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LRP1", "label": "LRP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MMP2", "label": "MMP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::\u0392-ACTIN", "label": "\u0392-ACTIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "label": "Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::C-MYC", "label": "C-MYC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDK2", "label": "CDK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IMP1", "label": "IMP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "label": "Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BRIP1", "label": "BRIP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CHEK1", "label": "CHEK1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "label": "Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FBXW7", "label": "FBXW7", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Shortcomings in the evaluation of biomarkers \r\nin ovarian cancer: a systematic review", "label": "Shortcomings in the evaluation of biomarkers \r\nin ovarian cancer: a systematic review", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "label": "The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HOXA9", "label": "HOXA9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HOXA10", "label": "HOXA10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HOXA11", "label": "HOXA11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK6", "label": "KLK6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK7", "label": "KLK7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK9", "label": "KLK9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MDK", "label": "MDK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PROS1", "label": "PROS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SLPI", "label": "SLPI", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IGFBP2", "label": "IGFBP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IGFBP3", "label": "IGFBP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GRN", "label": "GRN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RARRES2", "label": "RARRES2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD14", "label": "CD14", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MMP7", "label": "MMP7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL8", "label": "IL8", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "label": "The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HE4", "label": "HE4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BRCA", "label": "BRCA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "label": "The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAD51", "label": "RAD51", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PALB2", "label": "PALB2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAD51D", "label": "RAD51D", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MRE11", "label": "MRE11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAD50", "label": "RAD50", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NBS1", "label": "NBS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ATM", "label": "ATM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::H2AX", "label": "H2AX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MSH2", "label": "MSH2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MSH6", "label": "MSH6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PMS2", "label": "PMS2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAD52", "label": "RAD52", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "label": "The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "label": "The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FGFR2", "label": "FGFR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDC6", "label": "CDC6", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "label": "The biological significance and clinical applications of exosomes in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PDCD4", "label": "PDCD4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "label": "The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ARID1A", "label": "ARID1A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::STAT1", "label": "STAT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::APOBEC3A", "label": "APOBEC3A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CAPG", "label": "CAPG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LAYN", "label": "LAYN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CXCL9", "label": "CXCL9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CXCL11", "label": "CXCL11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CXCL13", "label": "CXCL13", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "label": "Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "label": "Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis", "label": "The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "label": "The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LGALS1", "label": "LGALS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LGALS3", "label": "LGALS3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LGALS7", "label": "LGALS7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LGALS8", "label": "LGALS8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LGAL9", "label": "LGAL9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LGALS9", "label": "LGALS9", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "label": "The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "label": "Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::D2R", "label": "D2R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GPR30", "label": "GPR30", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "label": "Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK4", "label": "KLK4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK5", "label": "KLK5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MSN", "label": "MSN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KRT19", "label": "KRT19", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL5A2", "label": "COL5A2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL1A2", "label": "COL1A2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BMP5", "label": "BMP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::F10", "label": "F10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KRT7", "label": "KRT7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::JUNB", "label": "JUNB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BMP4", "label": "BMP4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MMP1", "label": "MMP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "label": "ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZNF76", "label": "ZNF76", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDC5L", "label": "CDC5L", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DHX16", "label": "DHX16", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SNRPC", "label": "SNRPC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LSM2", "label": "LSM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CUL7", "label": "CUL7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PFDN6", "label": "PFDN6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VARS", "label": "VARS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HSD17B8", "label": "HSD17B8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPIL1", "label": "PPIL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RGL2", "label": "RGL2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GAPDH", "label": "GAPDH", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "label": "Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KRT18", "label": "KRT18", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KRT8", "label": "KRT8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDH1", "label": "CDH1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDH2", "label": "CDH2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AKT2", "label": "AKT2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SNAI2", "label": "SNAI2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WISP1", "label": "WISP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADAM8", "label": "ADAM8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK11", "label": "KLK11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FOLR1", "label": "FOLR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::APOA1", "label": "APOA1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TF", "label": "TF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TTR", "label": "TTR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::POU5F1", "label": "POU5F1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VEGFB", "label": "VEGFB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VEGFC", "label": "VEGFC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VEGFD", "label": "VEGFD", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PGF", "label": "PGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SPP1", "label": "SPP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "label": "KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KPNB1", "label": "KPNB1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis", "label": "Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::P53", "label": "P53", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "label": "HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "label": "Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "label": "Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LGALS4", "label": "LGALS4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "label": "Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ACAT1", "label": "ACAT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SOAT1", "label": "SOAT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RPL4", "label": "RPL4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ACTB", "label": "ACTB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IPO8", "label": "IPO8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TBP", "label": "TBP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RPLPO", "label": "RPLPO", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "label": "Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AURKA", "label": "AURKA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BRD4", "label": "BRD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VRK1", "label": "VRK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GALK1", "label": "GALK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HDAC4", "label": "HDAC4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FORL2", "label": "FORL2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PIK3R1", "label": "PIK3R1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GSK3B", "label": "GSK3B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MDM2", "label": "MDM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::STK15", "label": "STK15", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "label": "BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BAIAP2L1", "label": "BAIAP2L1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IRTKS", "label": "IRTKS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BAIAP2", "label": "BAIAP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BAIAP2L2", "label": "BAIAP2L2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FGFR3", "label": "FGFR3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FGFR3-BAIAP2L1", "label": "FGFR3-BAIAP2L1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "label": "Microvesicles as Potential Ovarian Cancer Biomarkers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EGFRVIII", "label": "EGFRVIII", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::F3", "label": "F3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PROM1", "label": "PROM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD40", "label": "CD40", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TGM2", "label": "TGM2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "label": "Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EN1", "label": "EN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HIC1", "label": "HIC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SPARC", "label": "SPARC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TGFBI", "label": "TGFBI", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FBXO32", "label": "FBXO32", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SFRP5", "label": "SFRP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADAMTS", "label": "ADAMTS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DVL1", "label": "DVL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NFATC3", "label": "NFATC3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ROCK1", "label": "ROCK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LRP5", "label": "LRP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NKD1", "label": "NKD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FZD4", "label": "FZD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::OPCML", "label": "OPCML", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ROR1", "label": "ROR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD24", "label": "CD24", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD117", "label": "CD117", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CCR2", "label": "CCR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HLA-G", "label": "HLA-G", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "label": "Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "label": "Biomarkers and Strategies for Early Detection of Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CHDH1", "label": "CHDH1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TFP12", "label": "TFP12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SRP5", "label": "SRP5", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review", "label": "Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "label": "Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MTSS1", "label": "MTSS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAD51AP1", "label": "RAD51AP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HMGA2", "label": "HMGA2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TIAM1", "label": "TIAM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KIT", "label": "KIT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK", "label": "KLK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DNMT3A", "label": "DNMT3A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DNMT3B", "label": "DNMT3B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TOP2A", "label": "TOP2A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::E2F3", "label": "E2F3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GCLC", "label": "GCLC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAS", "label": "RAS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PLK1", "label": "PLK1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "label": "CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SNAIL", "label": "SNAIL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::E-CADHERIN", "label": "E-CADHERIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "label": "CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CX3CR1", "label": "CX3CR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CX3CL1", "label": "CX3CL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ALKBH5", "label": "ALKBH5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HAVCR2", "label": "HAVCR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CSF1R", "label": "CSF1R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CXCR2", "label": "CXCR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CCR5", "label": "CCR5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD86", "label": "CD86", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HLA-DMA", "label": "HLA-DMA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HLA-DPA1", "label": "HLA-DPA1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "label": "A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LIN28A", "label": "LIN28A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::APAF1", "label": "APAF1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TGFB1", "label": "TGFB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SOCS3", "label": "SOCS3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAGEA3", "label": "MAGEA3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAGEA6", "label": "MAGEA6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NECTIN2", "label": "NECTIN2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PVR", "label": "PVR", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "label": "CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CXCR4", "label": "CXCR4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CXCL12", "label": "CXCL12", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "label": "Biomarkers in ovarian cancer: To be or not to be", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RBBP8", "label": "RBBP8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ATR", "label": "ATR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BLM", "label": "BLM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BARD1", "label": "BARD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NBN", "label": "NBN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::XRCC2", "label": "XRCC2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CHEK2", "label": "CHEK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MRE11A", "label": "MRE11A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SLX4", "label": "SLX4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FAM175A", "label": "FAM175A", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "label": "Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GYPC", "label": "GYPC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HAND2", "label": "HAND2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAL", "label": "MAL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZSCAN12", "label": "ZSCAN12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CADM1", "label": "CADM1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "label": "Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EZH2", "label": "EZH2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IRS2", "label": "IRS2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KEAP1", "label": "KEAP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "label": "Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DDB2", "label": "DDB2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "label": "Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCC", "label": "FANCC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRKDC", "label": "PRKDC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ATRX", "label": "ATRX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BAP1", "label": "BAP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BCL2L1", "label": "BCL2L1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::C11ORF65", "label": "C11ORF65", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CCNE1", "label": "CCNE1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCA", "label": "FANCA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCB", "label": "FANCB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCD2", "label": "FANCD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCE", "label": "FANCE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCF", "label": "FANCF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCG", "label": "FANCG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCI", "label": "FANCI", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCL", "label": "FANCL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FANCM", "label": "FANCM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GNAS", "label": "GNAS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAD2L2", "label": "MAD2L2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MUS81", "label": "MUS81", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MUTYH", "label": "MUTYH", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NDUFB2", "label": "NDUFB2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NF2", "label": "NF2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NRAS", "label": "NRAS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PARP1", "label": "PARP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PARP2", "label": "PARP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PAXIP1", "label": "PAXIP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PDGFRA", "label": "PDGFRA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PER3", "label": "PER3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPP2R1A", "label": "PPP2R1A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPP2R2A", "label": "PPP2R2A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAD54L", "label": "RAD54L", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RNASEH2A", "label": "RNASEH2A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RNASEH2B", "label": "RNASEH2B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RNASEH2C", "label": "RNASEH2C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RPA1", "label": "RPA1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RUNDC3B", "label": "RUNDC3B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SHFM1", "label": "SHFM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SLC25A40", "label": "SLC25A40", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SLFN11", "label": "SLFN11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TOE1", "label": "TOE1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TP53BP1", "label": "TP53BP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::UBE2T", "label": "UBE2T", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VRK2", "label": "VRK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ERCC4", "label": "ERCC4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "label": "Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "label": "Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TLX2", "label": "TLX2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PHOX2B", "label": "PHOX2B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FGF23", "label": "FGF23", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TIFAB", "label": "TIFAB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RNF223", "label": "RNF223", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HIST1H3A", "label": "HIST1H3A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AADACL4", "label": "AADACL4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NXF2B", "label": "NXF2B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MSLNL", "label": "MSLNL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PCGF1", "label": "PCGF1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::INO80B-WBP1", "label": "INO80B-WBP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LBX2", "label": "LBX2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MRPL53", "label": "MRPL53", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TTC31", "label": "TTC31", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WDR54", "label": "WDR54", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WBP1", "label": "WBP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "label": "A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAGE3", "label": "MAGE3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PDHA1", "label": "PDHA1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Confirmation of the utility of the  \r\nCA-125 elimination rate (KELIM) as an \r\nindicator of the chemosensitivity in \r\nadvanced-stage ovarian cancer in a \r\n\u201creal-life setting\u201d", "label": "Confirmation of the utility of the  \r\nCA-125 elimination rate (KELIM) as an \r\nindicator of the chemosensitivity in \r\nadvanced-stage ovarian cancer in a \r\n\u201creal-life setting\u201d", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::DEF6 expression in ovarian carcinoma correlates with poor patient survival", "label": "DEF6 expression in ovarian carcinoma correlates with poor patient survival", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "label": "Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DSG2", "label": "DSG2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DSG1", "label": "DSG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DSG3", "label": "DSG3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DSC1", "label": "DSC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DSC2", "label": "DSC2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DSC3", "label": "DSC3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CAR", "label": "CAR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADAMS", "label": "ADAMS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "label": "Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::C-ERBB2", "label": "C-ERBB2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "label": "Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GELSOLIN GENE", "label": "GELSOLIN GENE", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients", "label": "Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "label": "Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Diagnostic role of urine human epididymis protein 4 in ovarian cancer", "label": "Diagnostic role of urine human epididymis protein 4 in ovarian cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "label": "Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NUAK1", "label": "NUAK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ALPK2", "label": "ALPK2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SHKBP1", "label": "SHKBP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WBP1L", "label": "WBP1L", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ASAP3", "label": "ASAP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CNNM2", "label": "CNNM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NCAPH2", "label": "NCAPH2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CSE1L", "label": "CSE1L", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NUSAP1", "label": "NUSAP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AKR1B1", "label": "AKR1B1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SCRN1", "label": "SCRN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MIF", "label": "MIF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KIFAP3", "label": "KIFAP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CHI3L1", "label": "CHI3L1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::OXCT1", "label": "OXCT1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "label": "A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "label": "Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ALG5", "label": "ALG5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GPR107", "label": "GPR107", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NUP188", "label": "NUP188", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SUCLA2", "label": "SUCLA2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ATP5L", "label": "ATP5L", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MYLK3", "label": "MYLK3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "label": "Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DAPK", "label": "DAPK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZNF154", "label": "ZNF154", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PAX1", "label": "PAX1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PGR", "label": "PGR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::THBS1", "label": "THBS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SFRP1", "label": "SFRP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SFRP2", "label": "SFRP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SOX1", "label": "SOX1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TFPI2", "label": "TFPI2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EP300", "label": "EP300", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CALCA", "label": "CALCA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LMX1A", "label": "LMX1A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PAX5", "label": "PAX5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::C2CD4D", "label": "C2CD4D", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WNT6", "label": "WNT6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GPRIN1", "label": "GPRIN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RIPPLY3", "label": "RIPPLY3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SRC", "label": "SRC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SIM2", "label": "SIM2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "label": "Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SLIT2", "label": "SLIT2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DAPK1", "label": "DAPK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IGF2R", "label": "IGF2R", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAB25", "label": "RAB25", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CLDN4", "label": "CLDN4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Evaluation of HE4, CA-125, Risk of Ovarian \r\nMalignancy Algorithm (ROMA) and Risk of \r\nMalignancy Index (RMI) in the Preoperative \r\nAssessment of Patients with Adnexal Mass", "label": "Evaluation of HE4, CA-125, Risk of Ovarian \r\nMalignancy Algorithm (ROMA) and Risk of \r\nMalignancy Index (RMI) in the Preoperative \r\nAssessment of Patients with Adnexal Mass", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "label": "Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RECQL", "label": "RECQL", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "label": "Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NDRG1", "label": "NDRG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::C8ORF4", "label": "C8ORF4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TRPM7", "label": "TRPM7", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "label": "Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::XRCC5", "label": "XRCC5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GATA3", "label": "GATA3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ING5", "label": "ING5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LHX6", "label": "LHX6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SOX9", "label": "SOX9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FOSL2", "label": "FOSL2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ACTN4", "label": "ACTN4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::L1CAM", "label": "L1CAM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADAM10", "label": "ADAM10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BSG", "label": "BSG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ITGAV", "label": "ITGAV", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MET", "label": "MET", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PROKR1", "label": "PROKR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CAV1", "label": "CAV1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KDR", "label": "KDR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CEBPG", "label": "CEBPG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FMNL3", "label": "FMNL3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RFXAP", "label": "RFXAP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::B2M", "label": "B2M", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD274", "label": "CD274", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "label": "GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GNA15", "label": "GNA15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL2RG", "label": "IL2RG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ITGAM", "label": "ITGAM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LPXN", "label": "LPXN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MSR1", "label": "MSR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CCR1", "label": "CCR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ALOX5AP", "label": "ALOX5AP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PDCD1LG2", "label": "PDCD1LG2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "label": "Genetic characterization of early onset ovarian carcinoma", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "label": "Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HELQ", "label": "HELQ", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::POLQ", "label": "POLQ", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "label": "High BMP7 expression is associated with poor prognosis in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BMP7", "label": "BMP7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADAMTS19", "label": "ADAMTS19", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CAPN1", "label": "CAPN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CAPN2", "label": "CAPN2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CAPN4", "label": "CAPN4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CAST", "label": "CAST", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NOG", "label": "NOG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SMAD1", "label": "SMAD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SMAD5", "label": "SMAD5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SMAD8", "label": "SMAD8", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma", "label": "High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "label": "Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPP3CA", "label": "PPP3CA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPP3CB", "label": "PPP3CB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPP3CC", "label": "PPP3CC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPP3R1", "label": "PPP3R1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PPP3R2", "label": "PPP3R2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "label": "Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PKP1", "label": "PKP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PKP2", "label": "PKP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PKP3", "label": "PKP3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KRT13", "label": "KRT13", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NECTIN1", "label": "NECTIN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HHIPL1", "label": "HHIPL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RASSF7", "label": "RASSF7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADCY8", "label": "ADCY8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SP5", "label": "SP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KDM5A", "label": "KDM5A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EPS8L2", "label": "EPS8L2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ESRP1", "label": "ESRP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ANO9", "label": "ANO9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VTCN1", "label": "VTCN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL10RB", "label": "IL10RB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TNFRSF14", "label": "TNFRSF14", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::C10ORF54", "label": "C10ORF54", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TMEM173", "label": "TMEM173", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TAP2", "label": "TAP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HLA-DRB1", "label": "HLA-DRB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TAPBP", "label": "TAPBP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TNFRSF13C", "label": "TNFRSF13C", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "label": "Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CYP2E1", "label": "CYP2E1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "label": "A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL1RN", "label": "IL1RN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DKK1", "label": "DKK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PLAU", "label": "PLAU", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LCN2", "label": "LCN2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "label": "Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ARL6IP5", "label": "ARL6IP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD38", "label": "CD38", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DUOX1", "label": "DUOX1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GPR37", "label": "GPR37", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HGF", "label": "HGF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL18BP", "label": "IL18BP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAPK13", "label": "MAPK13", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MELK", "label": "MELK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MICB", "label": "MICB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NAPRT", "label": "NAPRT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NDUFB4", "label": "NDUFB4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::OGG1", "label": "OGG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PLA2R1", "label": "PLA2R1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SCGB1A1", "label": "SCGB1A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SIGMAR1", "label": "SIGMAR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SLC7A11", "label": "SLC7A11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SIRPA", "label": "SIRPA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TRPM2", "label": "TRPM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TTN", "label": "TTN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DNAH3", "label": "DNAH3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DNAH5", "label": "DNAH5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DNAH9", "label": "DNAH9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DNAH10", "label": "DNAH10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DNAH17", "label": "DNAH17", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LRP2", "label": "LRP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LRP1B", "label": "LRP1B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MGA", "label": "MGA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VCAN", "label": "VCAN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZFHX3", "label": "ZFHX3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PCLO", "label": "PCLO", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LCT", "label": "LCT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ARID1B", "label": "ARID1B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AIM1", "label": "AIM1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "label": "Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ARHGAP21", "label": "ARHGAP21", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ARMC3", "label": "ARMC3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::C7", "label": "C7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDH18", "label": "CDH18", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CES3", "label": "CES3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL3A1", "label": "COL3A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EHD3", "label": "EHD3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FRMPD2", "label": "FRMPD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GID4", "label": "GID4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GPR158", "label": "GPR158", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GRM5", "label": "GRM5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IGHG1", "label": "IGHG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::JCHAIN", "label": "JCHAIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KIF26B", "label": "KIF26B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAP7D2", "label": "MAP7D2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MTUS1", "label": "MTUS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MTRNR2L1", "label": "MTRNR2L1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MUC15", "label": "MUC15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PITHD1", "label": "PITHD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RTKN2", "label": "RTKN2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SLC9A4", "label": "SLC9A4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SMYD2", "label": "SMYD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TRIM71", "label": "TRIM71", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TRIO", "label": "TRIO", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TTK", "label": "TTK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VNN1", "label": "VNN1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "label": "Improved early detection of ovarian cancer using longitudinal multimarker models", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "label": "Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ABCG1", "label": "ABCG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BCRP", "label": "BCRP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ERBB4", "label": "ERBB4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NOTCH1", "label": "NOTCH1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::POSTN", "label": "POSTN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK8", "label": "KLK8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK13", "label": "KLK13", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AGR2", "label": "AGR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HNF1B", "label": "HNF1B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NFKB1", "label": "NFKB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RELA", "label": "RELA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NFKB2", "label": "NFKB2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FGFR1", "label": "FGFR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PDGFRB", "label": "PDGFRB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PLAUR", "label": "PLAUR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CLDN3", "label": "CLDN3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CLDN5", "label": "CLDN5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LPAR2", "label": "LPAR2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LPAR3", "label": "LPAR3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "label": "Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK15", "label": "KLK15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLK3", "label": "KLK3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial", "label": "Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "label": "Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EIF2B5", "label": "EIF2B5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FAM64A", "label": "FAM64A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ITGA3", "label": "ITGA3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PGM5", "label": "PGM5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BCL7A", "label": "BCL7A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ABCB9", "label": "ABCB9", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "label": "Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Metabonomics study of the serum from ovarian cancer patients", "label": "Metabonomics study of the serum from ovarian cancer patients", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::APOA4", "label": "APOA4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "label": "MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HMLH1", "label": "HMLH1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HMSH2", "label": "HMSH2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZEB2", "label": "ZEB2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HRAS", "label": "HRAS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CCND1", "label": "CCND1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ARHGAP19", "label": "ARHGAP19", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::E2F2", "label": "E2F2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::STK40", "label": "STK40", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ALK7", "label": "ALK7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NODAL", "label": "NODAL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IGF2", "label": "IGF2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MCL1", "label": "MCL1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DROSHA", "label": "DROSHA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TRBP", "label": "TRBP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SMAD2", "label": "SMAD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SMAD3", "label": "SMAD3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SMAD7", "label": "SMAD7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VEGFR2", "label": "VEGFR2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "label": "ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADAM12", "label": "ADAM12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL5A1", "label": "COL5A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ADAMTS12", "label": "ADAMTS12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::THBS2", "label": "THBS2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL1A1", "label": "COL1A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LUM", "label": "LUM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL5A3", "label": "COL5A3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL6A3", "label": "COL6A3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LOX", "label": "LOX", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ITGA11", "label": "ITGA11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FN1", "label": "FN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RPL32", "label": "RPL32", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "label": "MicroRNAs as Potential Biomarkers in Gynecological Cancers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CYP19A1", "label": "CYP19A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EIF2AK", "label": "EIF2AK", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SOX4", "label": "SOX4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TGFBR1", "label": "TGFBR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAPK1", "label": "MAPK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDC42", "label": "CDC42", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PAK1", "label": "PAK1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TCEAL7", "label": "TCEAL7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HIF3A", "label": "HIF3A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MYB", "label": "MYB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLF", "label": "KLF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZBTB4", "label": "ZBTB4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KIF4A", "label": "KIF4A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TP63", "label": "TP63", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "label": "Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::G6PDH", "label": "G6PDH", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BAK", "label": "BAK", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "label": "Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL1A", "label": "IL1A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DUSP1", "label": "DUSP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ITGB5", "label": "ITGB5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAPK3", "label": "MAPK3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAPK8", "label": "MAPK8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MCM2", "label": "MCM2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MCM5", "label": "MCM5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DNA2", "label": "DNA2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GAA", "label": "GAA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CTSA", "label": "CTSA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TCIRG1", "label": "TCIRG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CTSF", "label": "CTSF", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAB11FIP5", "label": "RAB11FIP5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAB5B", "label": "RAB5B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAB11A", "label": "RAB11A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LDLR", "label": "LDLR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HSPA1B", "label": "HSPA1B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GADD45A", "label": "GADD45A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDC7", "label": "CDC7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::YWHAG", "label": "YWHAG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDKN2C", "label": "CDKN2C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDT1", "label": "CDT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SQLE", "label": "SQLE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DHCR7", "label": "DHCR7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NSDHL", "label": "NSDHL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DHCR24", "label": "DHCR24", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LAPTM4A", "label": "LAPTM4A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NAGA", "label": "NAGA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RAB11FIP2", "label": "RAB11FIP2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::B3GNT1", "label": "B3GNT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ST3GAL3", "label": "ST3GAL3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FUT8", "label": "FUT8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::EHMT2", "label": "EHMT2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SDC1", "label": "SDC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DAG1", "label": "DAG1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "label": "Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ICAM1", "label": "ICAM1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "label": "Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LILRA2", "label": "LILRA2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::KLF6", "label": "KLF6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PDCD1", "label": "PDCD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LAG3", "label": "LAG3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CTLA4", "label": "CTLA4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TIGIT", "label": "TIGIT", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HLA-DPB1", "label": "HLA-DPB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HLA-DPB2", "label": "HLA-DPB2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "label": "Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::REDD1", "label": "REDD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RTP801", "label": "RTP801", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DIG1", "label": "DIG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::DDIT4", "label": "DDIT4", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "label": "PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD1", "label": "PSMD1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD2", "label": "PSMD2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD3", "label": "PSMD3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD4", "label": "PSMD4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD5", "label": "PSMD5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD6", "label": "PSMD6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD7", "label": "PSMD7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD8", "label": "PSMD8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD9", "label": "PSMD9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD10", "label": "PSMD10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD11", "label": "PSMD11", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD12", "label": "PSMD12", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD13", "label": "PSMD13", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMD14", "label": "PSMD14", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMC1", "label": "PSMC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMC2", "label": "PSMC2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMC3", "label": "PSMC3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMC4", "label": "PSMC4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMC5", "label": "PSMC5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PSMC6", "label": "PSMC6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SOX2", "label": "SOX2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HLA-A", "label": "HLA-A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HLA-C", "label": "HLA-C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TAP1", "label": "TAP1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IDO1", "label": "IDO1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TNFRSF4", "label": "TNFRSF4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD48", "label": "CD48", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AQN1", "label": "AQN1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ATG7", "label": "ATG7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ACVR1", "label": "ACVR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BMP6", "label": "BMP6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PKM", "label": "PKM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NFE2L2", "label": "NFE2L2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "label": "Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRKCG", "label": "PRKCG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SRD5A2", "label": "SRD5A2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CDK6", "label": "CDK6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NM1", "label": "NM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRKCA", "label": "PRKCA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRKCB", "label": "PRKCB", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GJA1", "label": "GJA1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::VEGFR", "label": "VEGFR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::XPC", "label": "XPC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ERCC2", "label": "ERCC2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "label": "Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRDX1", "label": "PRDX1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRDX2", "label": "PRDX2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRDX3", "label": "PRDX3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRDX5", "label": "PRDX5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PRDX6", "label": "PRDX6", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "label": "Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WASF3", "label": "WASF3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "label": "APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::APOC1", "label": "APOC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TYROBP", "label": "TYROBP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FCER1G", "label": "FCER1G", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LST1", "label": "LST1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::APOE", "label": "APOE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::GMFG", "label": "GMFG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::AIF1", "label": "AIF1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LILRB4", "label": "LILRB4", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ABI3", "label": "ABI3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZNF605", "label": "ZNF605", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WDR35", "label": "WDR35", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::BSN", "label": "BSN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZNF84", "label": "ZNF84", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ZNF638", "label": "ZNF638", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::STK36", "label": "STK36", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::WDR6", "label": "WDR6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HYDIN", "label": "HYDIN", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD80", "label": "CD80", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD163", "label": "CD163", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::CD206", "label": "CD206", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::IL10", "label": "IL10", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ARG1", "label": "ARG1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "label": "Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FLT3", "label": "FLT3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::ASXL1", "label": "ASXL1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic Significance of CA125 Dynamic \r\nChange for Progression Free Survival in Patients \r\nwith Epithelial Ovarian Carcinoma", "label": "Prognostic Significance of CA125 Dynamic \r\nChange for Progression Free Survival in Patients \r\nwith Epithelial Ovarian Carcinoma", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "label": "Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TGF-\u03921", "label": "TGF-\u03921", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TGF-\u03922", "label": "TGF-\u03922", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TGF-\u03923", "label": "TGF-\u03923", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::TGF-\u03924", "label": "TGF-\u03924", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LKB1", "label": "LKB1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "label": "Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NRF2", "label": "NRF2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "label": "Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::MAP1LC3B", "label": "MAP1LC3B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::SQSTM1", "label": "SQSTM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::PIK3C3", "label": "PIK3C3", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "label": "Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NOTCH3", "label": "NOTCH3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::HUR", "label": "HUR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::RUN6", "label": "RUN6", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "label": "Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::LAMB1", "label": "LAMB1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::COL6A1", "label": "COL6A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::NID1", "label": "NID1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "GENES::FXYD5", "label": "FXYD5", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "label": "Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "shape": "box"}]);
                  edges = new vis.DataSet([{"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "GENES::KRAS"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "GENES::BRAF"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "GENES::ERB-2"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "GENES::PTEN"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "GENES::TP-53"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "GENES::WFDC2"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "GENES::MUC1"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "GENES::MUC4"}, {"from": "ARTICLE::A Review on Emerging Biomarkers for Early Detection of \r\nOvarian Cancer", "to": "GENES::MUC16"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::AHRR"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::PPP1R3C"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::GALNT10"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::AHR"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::EGF"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::FGF"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::BID"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::CASP3"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::NOXA"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::CDKN2A"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::TERT"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::ALDH1A1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::CD44"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::ABCG2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::NANOG"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::ADRA1B"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::ADAM19"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::ADAMTS2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::COL23A1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::CPLX2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::FABP6"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::GABRA1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::GABRA6"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::GABRB2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::GABRP"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::HNRNPAB"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::KCNIP1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::LSM11"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::MAMDC2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::MFAP3"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::MKRN2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::MIR762HG"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::NDST1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::NEURL1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::NSD1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::PC"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::RANBP17"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::RNF130"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::SFXN1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::SH3PXD2B"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::SLIT3"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::TENM2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::UBTD2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::UIMC1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::ZNF346"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::NLRP12"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::PYROXD2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::RASGEF1C"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "GENES::TBC1D9B"}, {"from": "ARTICLE::RAD51 as a Biomarker for Homologous Recombination Deficiency in High\u2010Grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 test", "to": "GENES::BRCA1"}, {"from": "ARTICLE::RAD51 as a Biomarker for Homologous Recombination Deficiency in High\u2010Grade Serous Ovarian Carcinoma: Robustness and Interobserver Variability of the RAD51 test", "to": "GENES::BRCA2"}, {"from": "ARTICLE::nan", "to": "GENES::RIPK4"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::PAX8"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::MUC16"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::WFDC2"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::E2F1"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::E2F8"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::AURKB"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::CDCA5"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::CENPI"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::FOXM1"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::MYBL2"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "GENES::ABCB1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::TP53"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::RB1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::PTEN"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::NF1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::RAD51B"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::IGF1R"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::FGFR"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::ERBB2"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::EGFR"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::PDGFR"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::JAK1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::JAK2"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::STAT3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::CTNNB1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::AXIN1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::APC"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::MUC16"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::RUNX3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::CAMK2N1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::ARNTL"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::FKBP1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::PAX9"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::COL11A1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::FOXM1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::CD44"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::IL6"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::IL6ST"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::RIPK3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::MLKL"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::AKT1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::BCL2"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::CASP3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::CASP8"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::CASP9"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::BAX"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::BAD"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::BECN1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::ERBB3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::PRKCI"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::IL6R"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::STK11"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::SIRT3"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::RBP4"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::ALDH"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "GENES::FOXR2"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "GENES::WFDC2"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::MUC16"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::MSLN"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::PTEN"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::RGS2"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::FAM83A"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::MYO18B"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::MSX1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::TMEM88"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::CDK12"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::RAD51C"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::EMSY"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::MLH1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::RASSF1A"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::ATG4A"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::HIST1H2BN"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::ERCC1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::PPIC"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::RRM1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::RRM2"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::MRP1"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "GENES::MDR1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::KRAS"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::TP53"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::HMBOX1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::LIAS"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::MTR"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::NUDT4"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::MPHOSPH8"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::FOXP1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::TWIST1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::YAP1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::VEGFA"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::STK11"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::PIK3R3"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "GENES::CLDN1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::MYC"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::SMAD4"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::TP53"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::RUNX3"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::EBF1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::NF1C"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::ATF2"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::MMP3"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::MMP9"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::CDKN1A"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::SNAI1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::VIM"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::ZEB1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::MMP14"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::CDKN2B"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "GENES::TIMP1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::PTEN"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::ZEB1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::BCL10"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::S1PR1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::ESR1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::RUNX2"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::ITGA5"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::PCDH9"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::KLF12"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::HK2"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::BIRC5"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::FBXL10"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::DICER1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::DGCR8"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::XPO5"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::RAN"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::AGO2"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::TARBP2"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::PRKRA"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::PIK3CA"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::PIK3CB"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::AKT1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::ABCB1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::GSTP1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::NAV3"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::MAP3K7"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::HNRNPC"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::NFIX"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::CHD4"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::IRAK1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::TRAF6"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::HIF1A"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::EPAS1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::CD44"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::TAK1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::CXCL1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::CXCL8"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "GENES::TNF"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::EPCAM"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::HER2"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::MUC1"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::WT1"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::P16"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::PAX8"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::ERCC1"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::PPIC"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::CK20"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::EGFR"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::CK8"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::CK18"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "GENES::TFS-2"}, {"from": "ARTICLE::Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas", "to": "GENES::BRCA2"}, {"from": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "to": "GENES::SLC11A2"}, {"from": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "GENES::SPON1"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "GENES::SPON1-NRG2\u0391"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "GENES::SPON1-TRIM29"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::SUGT1"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::PAX3"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::FOXO1"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::EWS"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::FLI1"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::GTF2F2"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::NUFIP1"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::TRIM13"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::MED4"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::GPALPP1"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::UBE2L6"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::NUDT8"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::PLAAT4"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::LGALS17A"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::PIGR"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::KRAS"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::IL6"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::JAK"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::STAT3"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::MTOR"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "GENES::TNFA"}, {"from": "ARTICLE::Serum CA125, CA199 and CEA combined detection \r\nfor epithelial ovarian cancer diagnosis: A meta\r\nanalysis", "to": "GENES::MUC16"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "GENES::LRP1"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "GENES::MMP2"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "GENES::MMP9"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "GENES::\u0392-ACTIN"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "GENES::C-MYC"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "GENES::CDK2"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "GENES::IMP1"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "GENES::MUC16"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "GENES::BRIP1"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "GENES::CHEK1"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "GENES::RAD51C"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "GENES::TWIST1"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "GENES::FBXW7"}, {"from": "ARTICLE::Shortcomings in the evaluation of biomarkers \r\nin ovarian cancer: a systematic review", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Shortcomings in the evaluation of biomarkers \r\nin ovarian cancer: a systematic review", "to": "GENES::BRCA2"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::HOXA9"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::HOXA10"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::HOXA11"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::KRAS"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::PTEN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::WFDC2"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::MUC16"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::MUC1"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::KLK6"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::KLK7"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::KLK9"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::MDK"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::PROS1"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::SLPI"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::TIMP1"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::IGFBP2"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::IGFBP3"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::GRN"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::RARRES2"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::CD14"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::MMP7"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::VEGFA"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::IL8"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "GENES::EPCAM"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "GENES::HE4"}, {"from": "ARTICLE::The Role of Interleukin 6 (IL6), Cancer Antigen\u2014125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients", "to": "GENES::BRCA"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::RAD51"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::PALB2"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::RAD51B"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::RAD51C"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::RAD51D"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::MRE11"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::RAD50"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::NBS1"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::ATM"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::H2AX"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::MLH1"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::MSH2"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::MSH6"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::PMS2"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::The Role of Tumor Biomarkers in Tailoring the Approach to Advanced Ovarian Cancer", "to": "GENES::RAD52"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "GENES::ABCG2"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "GENES::FGFR2"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "GENES::C-MYC"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "GENES::CDC6"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "GENES::PDCD4"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::ARID1A"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::STAT1"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::APOBEC3A"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::CAPG"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::LAYN"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::CXCL9"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::CXCL11"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "GENES::CXCL13"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "GENES::TP53"}, {"from": "ARTICLE::Sensitive and Cost\u2010Effective Tools in the Detection of Ovarian Cancer Biomarkers", "to": "GENES::PTEN"}, {"from": "ARTICLE::Exosomal biomarkers in the differential \ndiagnosis of ovarian tumors: the emerging \nroles of CA125, HE4, and C5a", "to": "GENES::MUC16"}, {"from": "ARTICLE::The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis", "to": "GENES::BRCA1"}, {"from": "ARTICLE::The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis", "to": "GENES::BRCA2"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "GENES::LGALS1"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "GENES::LGALS3"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "GENES::LGALS7"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "GENES::LGALS8"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "GENES::LGAL9"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "GENES::LGALS9"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::BRCA1"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::BRCA2"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::MSH2"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::MSH6"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::MLH1"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::PMS2"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::EPCAM"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::BRIP1"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::PALB2"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::RAD51C"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::RAD51D"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "GENES::TP53"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "GENES::BRCA"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "GENES::D2R"}, {"from": "ARTICLE::Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer", "to": "GENES::GPR30"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::KLK4"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::KLK5"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::KLK6"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::KLK7"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::MSN"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::KRT19"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::COL5A2"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::COL1A2"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::BMP5"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::F10"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::KRT7"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::JUNB"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::BMP4"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "GENES::MMP1"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::ZNF76"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::CDC5L"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::DHX16"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::SNRPC"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::LSM2"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::CUL7"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::PFDN6"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::VARS"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::HSD17B8"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::PPIL1"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::RGL2"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::GAPDH"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::WFDC2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::MUC16"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::MUC1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::EPCAM"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::WT1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::KRT7"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::KRT18"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::KRT19"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::KRT8"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::CDH1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::CDH2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::VIM"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::CD44"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::EGFR"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::ERBB2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::PIK3CA"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::AKT2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::TWIST1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::ZEB1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::SNAI2"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::MMP7"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::MDK"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::CXCL13"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::WISP1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::ADAM8"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::KLK11"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::FOLR1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::MSLN"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::APOA1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::TF"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::TTR"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::ALDH1A1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::POU5F1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::NANOG"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::ERCC1"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::MUC4"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::VEGFA"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::VEGFB"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::VEGFC"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::VEGFD"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::PGF"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "GENES::SPP1"}, {"from": "ARTICLE::KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis", "to": "GENES::KPNB1"}, {"from": "ARTICLE::Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis", "to": "GENES::P53"}, {"from": "ARTICLE::Usefulness of Amino Acid Profiling in Ovarian Cancer Screening with Special Emphasis on Their Role in Cancerogenesis", "to": "GENES::C-MYC"}, {"from": "ARTICLE::HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer", "to": "GENES::MMP7"}, {"from": "ARTICLE::Assessing Lead Time of Selected Ovarian Cancer \r\nBiomarkers: A Nested Case \u2013 Control Study", "to": "GENES::WFDC2"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "GENES::LGALS1"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "GENES::LGALS3"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "GENES::LGALS4"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "GENES::LGALS8"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "GENES::LGALS9"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "GENES::GAPDH"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "GENES::ACAT1"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "GENES::SOAT1"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "GENES::RPL4"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "GENES::ACTB"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "GENES::GAPDH"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "GENES::IPO8"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "GENES::TBP"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "GENES::RPLPO"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::AURKA"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::ERBB3"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::CDK2"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::MTOR"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::BRD4"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::VRK1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::GALK1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::HDAC4"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::STAT1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::FORL2"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::PIK3R1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::GSK3B"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::MYC"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::TP53"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::MDM2"}, {"from": "ARTICLE::Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients", "to": "GENES::STK15"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "GENES::BAIAP2L1"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "GENES::IRTKS"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "GENES::BAIAP2"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "GENES::BAIAP2L2"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "GENES::FGFR3"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "GENES::FGFR3-BAIAP2L1"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "GENES::EGFR"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "GENES::EGFRVIII"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "GENES::ERBB2"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "GENES::F3"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "GENES::PROM1"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "GENES::CD40"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "GENES::TGM2"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::KRAS"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::BRAF"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::PTEN"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::ARID1A"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::TP53"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::MUC16"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::MLH1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::HOXA9"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::EN1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::HIC1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::SPARC"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::TGFBI"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::FBXO32"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::SFRP5"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::FOLR1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::RAD50"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::ADAMTS"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::DVL1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::NFATC3"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::ROCK1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::LRP5"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::AXIN1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::NKD1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::FZD4"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::OPCML"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::ROR1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::PROM1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::CD44"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::CD24"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::CD117"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::EPCAM"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::ABCG2"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::ALDH1A1"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::CCR2"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "GENES::HLA-G"}, {"from": "ARTICLE::Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient\u2019s plasma \u2013 a prospective trial", "to": "GENES::P53"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "GENES::APC"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "GENES::RASSF1A"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "GENES::CHDH1"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "GENES::RUNX3"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "GENES::TFP12"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "GENES::SRP5"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "GENES::OPCML"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review", "to": "GENES::MUC16"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::MTSS1"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::RAD51AP1"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::HMGA2"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::PTEN"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::BCL2"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::TIAM1"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::CD44"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::KIT"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::KLK"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::DNMT3A"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::DNMT3B"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::TOP2A"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::E2F3"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::GCLC"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::RAS"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::PLK1"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "GENES::ABCG2"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "GENES::CD24"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "GENES::SNAIL"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "GENES::E-CADHERIN"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::CX3CR1"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::CX3CL1"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::ALKBH5"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::HAVCR2"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::CSF1R"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::CXCR2"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::CCR5"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::CD86"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::HLA-DMA"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "GENES::HLA-DPA1"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::LIN28A"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::NAV3"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::APAF1"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::TGFB1"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::SOCS3"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::STAT3"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::MAGEA3"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::MAGEA6"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::NECTIN2"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "GENES::PVR"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "GENES::CXCR4"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "GENES::CXCL12"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "GENES::GAPDH"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::BRIP1"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::ATM"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::RAD51C"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::RAD51D"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::RBBP8"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::PALB2"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::ATR"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::BLM"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::BARD1"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::NBN"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::XRCC2"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::CHEK2"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::MRE11A"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::SLX4"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::TP53"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::CHEK1"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "GENES::FAM175A"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::EPCAM"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::GYPC"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::HAND2"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::MAL"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::MLH1"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::MSH2"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::MSH6"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::PMS2"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::TP53"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::ZSCAN12"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "GENES::CADM1"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "GENES::EZH2"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "GENES::IRS2"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "GENES::KEAP1"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::KRAS"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::PIK3CA"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::APC"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::DDB2"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::FGFR2"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::RAD51C"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::RAD51D"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::OPCML"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "GENES::HOXA9"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::ABCB1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::ARID1A"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::ATM"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::ATR"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::CTNNB1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCC"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::KRAS"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::MSH2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::NF1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PIK3CA"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PRKDC"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PTEN"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RB1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::SLX4"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::TP53"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::ATRX"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::BAP1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::BARD1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::BCL2L1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::BLM"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::BRAF"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::BRIP1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::C11ORF65"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::CCNE1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::CDK12"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::CHD4"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::CHEK1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::CHEK2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::EGFR"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::EMSY"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCA"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCB"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCD2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCE"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCF"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCG"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCI"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCL"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::FANCM"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::GNAS"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::KIT"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::MAD2L2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::MDM2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::MLH1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::MSH6"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::MUS81"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::MUTYH"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::NBN"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::NDUFB2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::NF2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::NRAS"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PALB2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PARP1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PARP2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PAXIP1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PDGFRA"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PER3"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PMS2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PPP2R1A"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::PPP2R2A"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RAD50"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RAD51"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RAD51B"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RAD51C"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RAD54L"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RNASEH2A"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RNASEH2B"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RNASEH2C"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RPA1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::RUNDC3B"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::SHFM1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::SLC25A40"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::SLFN11"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::TOE1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::TP53BP1"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::UBE2T"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::VRK2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::ERBB2"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::ERCC4"}, {"from": "ARTICLE::Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse", "to": "GENES::EZH2"}, {"from": "ARTICLE::Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::TLX2"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::PHOX2B"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::FGF23"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::TIFAB"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::RNF223"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::HIST1H3A"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::AADACL4"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::NXF2B"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::MSLNL"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::PCGF1"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::INO80B-WBP1"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::LBX2"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::MRPL53"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::TTC31"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::WDR54"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::WBP1"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::GAPDH"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "GENES::TERT"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "GENES::MAGE3"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "GENES::PDHA1"}, {"from": "ARTICLE::A metabolic fingerprint of ovarian cancer: a novel diagnostic strategy employing plasma EV-based metabolomics and machine learning algorithms", "to": "GENES::SIRT3"}, {"from": "ARTICLE::Confirmation of the utility of the  \r\nCA-125 elimination rate (KELIM) as an \r\nindicator of the chemosensitivity in \r\nadvanced-stage ovarian cancer in a \r\n\u201creal-life setting\u201d", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Confirmation of the utility of the  \r\nCA-125 elimination rate (KELIM) as an \r\nindicator of the chemosensitivity in \r\nadvanced-stage ovarian cancer in a \r\n\u201creal-life setting\u201d", "to": "GENES::BRCA2"}, {"from": "ARTICLE::DEF6 expression in ovarian carcinoma correlates with poor patient survival", "to": "GENES::RB1"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "GENES::DSG2"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "GENES::DSG1"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "GENES::DSG3"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "GENES::DSC1"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "GENES::DSC2"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "GENES::DSC3"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "GENES::EGFR"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "GENES::CAR"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "GENES::ADAMS"}, {"from": "ARTICLE::Detection and analysis of multiple biomarkers in ovarian cancer: \r\nclinical significance in diagnosis, treatment, and prognosis \r\nevaluation", "to": "GENES::C-ERBB2"}, {"from": "ARTICLE::Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum", "to": "GENES::GELSOLIN GENE"}, {"from": "ARTICLE::Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Diagnostic Value of Human Epididymis Protein 4 Compared \r\nwith Mesothelin for Ovarian Cancer: a Systematic Review and \r\nMeta-analysis", "to": "GENES::WFDC2"}, {"from": "ARTICLE::Diagnostic role of urine human epididymis protein 4 in ovarian cancer", "to": "GENES::WFDC2"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::NUAK1"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::ALPK2"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::SHKBP1"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::WBP1L"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::ASAP3"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::CNNM2"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::NCAPH2"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::CSE1L"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::CHEK2"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::BRIP1"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::MSH2"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::NUSAP1"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::AKR1B1"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::MAL"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::SCRN1"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::MIF"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::KIFAP3"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::CHI3L1"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::CSF1R"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "GENES::OXCT1"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "GENES::WFDC2"}, {"from": "ARTICLE::A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients", "to": "GENES::MUC16"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "GENES::ALG5"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "GENES::GPR107"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "GENES::NUP188"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "GENES::CCNE1"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "GENES::SUCLA2"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "GENES::ATP5L"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "GENES::MYLK3"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::APC"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::OPCML"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::RASSF1A"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::DAPK"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::HIC1"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::HOXA9"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::RUNX3"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::ZNF154"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::PAX1"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::PGR"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::THBS1"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::SFRP1"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::SFRP2"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::SFRP5"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::SOX1"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::TFPI2"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::CDH1"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::EP300"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::CALCA"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::LMX1A"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::PAX5"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::COL23A1"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::C2CD4D"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::WNT6"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::GPRIN1"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::GYPC"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::RIPPLY3"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::SRC"}, {"from": "ARTICLE::Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review", "to": "GENES::SIM2"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::TP53"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::RASSF1A"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::ESR1"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::SLIT2"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::PAX1"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::PTEN"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::CDH1"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::RUNX3"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::APC"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::DAPK1"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::CDKN2A"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::PGR"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::CALCA"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::EP300"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::HOXA9"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::OPCML"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::TFPI2"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::SFRP1"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::SFRP5"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::COL23A1"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::IGF2R"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::RAB25"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::CLDN4"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::EGFR"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::BRAF"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::KRAS"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::PIK3CA"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::HIC1"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::SOX1"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::PAX5"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "GENES::LMX1A"}, {"from": "ARTICLE::Evaluation of HE4, CA-125, Risk of Ovarian \r\nMalignancy Algorithm (ROMA) and Risk of \r\nMalignancy Index (RMI) in the Preoperative \r\nAssessment of Patients with Adnexal Mass", "to": "GENES::WFDC2"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::MSH6"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::RAD51C"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::RAD51D"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::BRIP1"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::ATM"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::BLM"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::CHEK2"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::FANCM"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::MRE11A"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::NBN"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::NF1"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::PALB2"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::RAD50"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::RECQL"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::MLH1"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::MSH2"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::PMS2"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "GENES::NDRG1"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "GENES::C8ORF4"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "GENES::TRPM7"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::TP53"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::XRCC5"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::APAF1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::CDKN1A"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::GATA3"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::ING5"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::LHX6"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::SOX9"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::FOSL2"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::MUC4"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::ACTN4"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::CD44"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::L1CAM"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::ADAM10"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::BSG"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::ITGAV"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::MET"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::PROKR1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::STAT3"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::CAV1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::PTEN"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::KDR"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::VEGFA"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::MMP1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::FOXP1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::CEBPG"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::FMNL3"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::RFXAP"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::B2M"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "GENES::CD274"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "GENES::GNA15"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "GENES::IL2RG"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "GENES::ITGAM"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "GENES::LPXN"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "GENES::MSR1"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "GENES::CCR1"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "GENES::ALOX5AP"}, {"from": "ARTICLE::GNA15 predicts poor outcomes\n as a novel biomarker related to\n M2 macrophage infiltration in\n ovarian cancer", "to": "GENES::PDCD1LG2"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::BRIP1"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::RAD51C"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::RAD51D"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::PALB2"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::BARD1"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::MSH2"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::MLH1"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::PMS2"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::MSH6"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::ATM"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::BAP1"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::CHEK2"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::MRE11A"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::NBN"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::PTEN"}, {"from": "ARTICLE::Genetic characterization of early onset ovarian carcinoma", "to": "GENES::TP53"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "GENES::HELQ"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "GENES::RAD51"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "GENES::GAPDH"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "GENES::POLQ"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::BMP7"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::ADAMTS19"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::SFRP1"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::CAPN1"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::CAPN2"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::CAPN4"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::CAST"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::NOG"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::SMAD1"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::SMAD5"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::SMAD8"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "GENES::SMAD4"}, {"from": "ARTICLE::High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma", "to": "GENES::MUC16"}, {"from": "ARTICLE::High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma", "to": "GENES::WT1"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "GENES::PPP3CA"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "GENES::PPP3CB"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "GENES::PPP3CC"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "GENES::PPP3R1"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "GENES::PPP3R2"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::PKP1"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::PKP2"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::PKP3"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::TP53"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::EGFR"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::KRT13"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::NECTIN1"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::HHIPL1"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::RASSF7"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::ADCY8"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::SP5"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::KDM5A"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::EPS8L2"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::ESRP1"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::ANO9"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::LGALS9"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::VTCN1"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::IL10RB"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::TNFRSF14"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::C10ORF54"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::TMEM173"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::TAP2"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::HLA-DRB1"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::TAPBP"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "GENES::TNFRSF13C"}, {"from": "ARTICLE::Identification of Potential Biomarkers and \r\nMetabolic Profiling of Serum in Ovarian \r\nCancer Patients Using UPLC/Q-TOF MS", "to": "GENES::CYP2E1"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::IL1RN"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::IL6"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::DKK1"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::PLAU"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::CDH1"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::ERBB2"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::SLPI"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::WFDC2"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::MUC16"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::LCN2"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::MSLN"}, {"from": "ARTICLE::A Novel Multiple Biomarker Panel for the Early Detection of High-grade Serous Ovarian Carcinoma", "to": "GENES::SPP1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::ARL6IP5"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::CD38"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::DUOX1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::FOXO1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::GPR37"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::HGF"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::IL18BP"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::MAPK13"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::MELK"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::MICB"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::NAPRT"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::NDUFB4"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::OGG1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::PLA2R1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::SCGB1A1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::SIGMAR1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::SLC7A11"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::SIRPA"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::TRPM2"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::JAK2"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::TTN"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::DNAH3"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::DNAH5"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::DNAH9"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::DNAH10"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::DNAH17"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::LRP2"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::LRP1B"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::MGA"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::VCAN"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::ZFHX3"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::PCLO"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::LCT"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::ARID1B"}, {"from": "ARTICLE::Identifying the Role of Oxidative Stress-Related Genes as\r\n Prognostic Biomarkers and Predicting the Response of\r\n Immunotherapy and Chemotherapy in Ovarian Cancer", "to": "GENES::AIM1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::ARHGAP21"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::ARMC3"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::C7"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::CDH18"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::CES3"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::COL11A1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::COL3A1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::EHD3"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::FRMPD2"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::GABRP"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::GID4"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::GPR158"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::GRM5"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::IGHG1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::JCHAIN"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::KIF26B"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::MAP7D2"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::MTUS1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::MTRNR2L1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::MUC15"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::PITHD1"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::PTEN"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::RTKN2"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::SLC9A4"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::SMYD2"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::TRIM71"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::TRIO"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::TTK"}, {"from": "ARTICLE::Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas", "to": "GENES::VNN1"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "GENES::TP53"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "GENES::MYC"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "GENES::KRAS"}, {"from": "ARTICLE::Improved early detection of ovarian cancer using longitudinal multimarker models", "to": "GENES::WFDC2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::ABCB1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::ABCG1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::ABCG2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::BCRP"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::ERBB2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::ERBB3"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::ERBB4"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::EGFR"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::NOTCH1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::FOLR1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::MUC16"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::MSLN"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::POSTN"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::KLK5"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::KLK6"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::KLK7"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::KLK8"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::KLK11"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::KLK13"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::AGR2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::HNF1B"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::TP53"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::TNF"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::JAK1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::JAK2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::STAT3"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::NFKB1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::RELA"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::NFKB2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::KRAS"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::PTEN"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::AKT1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::PIK3CA"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::HIF1A"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::VEGFA"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::KDR"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::FGFR1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::PDGFRB"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::IGF1R"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::TGFB1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::HGF"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::PLAU"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::PLAUR"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::SPP1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::MMP2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::MMP9"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::CLDN3"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::CLDN4"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::CLDN5"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::CXCL8"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::IL6"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::IL6R"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::LPAR2"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::LPAR3"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::PARP1"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "GENES::CDH1"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "GENES::KLK5"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "GENES::KLK7"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "GENES::KLK11"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "GENES::KLK8"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "GENES::KLK4"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "GENES::KLK6"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "GENES::KLK15"}, {"from": "ARTICLE::Kallikrein expression as a prognostic factor in ovarian cancer: \r\na systematic review and meta-analysis", "to": "GENES::KLK3"}, {"from": "ARTICLE::Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial", "to": "GENES::WFDC2"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "GENES::EIF2B5"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "GENES::FAM64A"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "GENES::ITGA3"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "GENES::PGM5"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "GENES::BCL7A"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "GENES::ABCB9"}, {"from": "ARTICLE::Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "to": "GENES::MSLN"}, {"from": "ARTICLE::Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis", "to": "GENES::MUC16"}, {"from": "ARTICLE::Metabonomics study of the serum from ovarian cancer patients", "to": "GENES::APOA4"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::HMLH1"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::HMSH2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::WFDC2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::ZEB1"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::ZEB2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::HMGA2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::KRAS"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::HRAS"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::MYC"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::PTEN"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::ERBB2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::ERBB4"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::EGFR"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::CCND1"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::ARHGAP19"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::E2F2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::STK40"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::ALK7"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::NODAL"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::PDGFRA"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::IGF2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::MCL1"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::PDCD4"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::BCL2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::MMP3"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::AGO2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::DROSHA"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::DICER1"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::DGCR8"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::XPO5"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::TRBP"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::SMAD2"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::SMAD3"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::SMAD7"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::JAK"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::STAT3"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::VEGFA"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "GENES::VEGFR2"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::ADAM12"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::COL5A2"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::COL3A1"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::POSTN"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::COL5A1"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::ADAMTS12"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::THBS2"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::COL1A1"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::COL11A1"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::MMP2"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::LUM"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::COL5A3"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::COL6A3"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::COL1A2"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::LOX"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::SNAI2"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::ITGA11"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::VCAN"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::FN1"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "GENES::RPL32"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::BRCA1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::BRCA2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::PTEN"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::PIK3CA"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::CTNNB1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::BRAF"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::KRAS"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::HRAS"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::TP53"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::ERBB2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::MUC16"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::WFDC2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::HNF1B"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::CYP19A1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::EIF2AK"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::MYC"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::SOX4"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::TGFBR1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::SMAD2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::HMGA2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::CDKN2A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::AKT1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::MAPK1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::CDC42"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::PAK1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::ZEB1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::ZEB2"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::TCEAL7"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::VEGFA"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::HIF1A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::HIF3A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::MYB"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::CCND1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::GSK3B"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::KLF"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::ZBTB4"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::KIF4A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "GENES::TP63"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "GENES::CHI3L1"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "GENES::G6PDH"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "GENES::MCL1"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "GENES::BCL2"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "GENES::BAK"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "GENES::BAX"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::IL1A"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::DUSP1"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::COL1A1"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::ITGB5"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::MAPK3"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::MAPK8"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::EP300"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::CDKN1A"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::MCM2"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::MCM5"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::DNA2"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::RPA1"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::GAA"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::CTSA"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::TCIRG1"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::CTSF"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::RAB11FIP5"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::RAB5B"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::RAB11A"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::LDLR"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::HSPA1B"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::GADD45A"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::CDC7"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::YWHAG"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::CDKN2C"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::CDT1"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::SQLE"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::DHCR7"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::NSDHL"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::DHCR24"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::LAPTM4A"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::NAGA"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::RAB11FIP2"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::B3GNT1"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::ST3GAL3"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::FUT8"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::EHMT2"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::SDC1"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "GENES::DAG1"}, {"from": "ARTICLE::Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "to": "GENES::ICAM1"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::LILRA2"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::KLF6"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::PDCD1"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::CD274"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::PDCD1LG2"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::LAG3"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::CTLA4"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::HAVCR2"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::TIGIT"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::HLA-DPB1"}, {"from": "ARTICLE::Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target", "to": "GENES::HLA-DPB2"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "GENES::REDD1"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "GENES::RTP801"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "GENES::DIG1"}, {"from": "ARTICLE::Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma", "to": "GENES::DDIT4"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD2"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD3"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD4"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD5"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD6"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD7"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD8"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD9"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD10"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD11"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD12"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD13"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMD14"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMC1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMC2"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMC3"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMC4"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMC5"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PSMC6"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::TP53"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::RB1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::E2F1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::ERBB2"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::AKT1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::SOX2"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::HLA-A"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::HLA-C"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::B2M"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::TAP1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::MMP9"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::IDO1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::IL10RB"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PVR"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::TNFRSF4"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::MICB"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::CD48"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::AQN1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::ATG7"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::ACVR1"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::BMP6"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::PKM"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "GENES::NFE2L2"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::PRKCG"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::AURKA"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::CYP19A1"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::SRD5A2"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::RB1"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::CDK6"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::CDK12"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::RAD51"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::XRCC2"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::NM1"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::CCND1"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::PRKCA"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::PRKCB"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::GJA1"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::EGFR"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::VEGFR"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::FGFR"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::ERCC1"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::XPC"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::PIK3CA"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::ERBB2"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::ERCC2"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "GENES::CXCR4"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "GENES::PRDX1"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "GENES::PRDX2"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "GENES::PRDX3"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "GENES::PRDX5"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "GENES::PRDX6"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "GENES::BRCA"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "GENES::C-MYC"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "GENES::BRCA1"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "GENES::BRCA2"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "GENES::WASF3"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::APOC1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::BRCA1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::BRCA2"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::TYROBP"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::FCER1G"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::CD48"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::LST1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::APOE"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::GMFG"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::HAVCR2"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::AIF1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::LILRB4"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::ABI3"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::ZNF605"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::WDR35"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::BSN"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::ZNF84"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::ZNF638"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::STK36"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::WDR6"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::CHD4"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::HYDIN"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::CD80"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::CD86"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::CD163"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::CD206"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::IL10"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::ARG1"}, {"from": "ARTICLE::APOC1 is a prognostic biomarker associated \r\nwith M2 macrophages in ovarian cancer", "to": "GENES::GAPDH"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::KRAS"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::PIK3CA"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::PIK3R1"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::BRAF"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::FLT3"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::KIT"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::ASXL1"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::ERBB2"}, {"from": "ARTICLE::Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer", "to": "GENES::BRCA"}, {"from": "ARTICLE::Prognostic Significance of CA125 Dynamic \r\nChange for Progression Free Survival in Patients \r\nwith Epithelial Ovarian Carcinoma", "to": "GENES::MUC16"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "GENES::TP53"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "GENES::TGF-\u03921"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "GENES::TGF-\u03922"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "GENES::TGF-\u03923"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "GENES::TGF-\u03924"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "GENES::ZEB2"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "GENES::LKB1"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "GENES::NRF2"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "GENES::KEAP1"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "GENES::P16"}, {"from": "ARTICLE::Prognostic and predictive values of Nrf2, Keap1, p16 \r\nand E-cadherin expression in ovarian  \r\nepithelial carcinoma", "to": "GENES::P53"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "GENES::BECN1"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "GENES::MAP1LC3B"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "GENES::SQSTM1"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "GENES::PIK3C3"}, {"from": "ARTICLE::Prognostic relevance of \r\nautophagy-related markers \r\np62, LC3, and Beclin1 in \r\novarian cancer", "to": "GENES::BCL2"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "GENES::NOTCH3"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "GENES::HUR"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "GENES::TBP"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "GENES::RUN6"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "GENES::PLAU"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "GENES::LAMB1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "GENES::COL6A1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "GENES::TGFB1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "GENES::TP53"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "GENES::NID1"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "GENES::FXYD5"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "GENES::COL5A2"}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {"interaction": {"hover": false, "tooltipDelay": 999999}};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>